HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Trump's Budget Blueprint: Cosmetics Opportunity Or Unhelpful Distraction?

This article was originally published in The Rose Sheet

Executive Summary

President Trump appears to want greater user-fee contributions from FDA-regulated industries to offset cuts to federal spending in fiscal 2018. His recently released budget blueprint could complicate negotiations that cosmetics stakeholders were hoping to join, but it also could signal opportunity for an industry seeking increased regulation – and willing to pay for it.


Related Content

Trump's Budget Surprise: FDA Gets 13% Increase
Gottlieb Becomes FDA Commissioner With Immediate Issues Pending
FDA Gains Budget Increase In FY 2017 … And Not Through Fees
Risks Of Missing Reauthorization Deadline Highlighted At User-Fee Hearing
FDA Commish Nominee Could Be Mixed Blessing For Cosmetics Industry
Cosmetics Stakeholders Race To Hitch Reform Provisions To FDA User-Fee Bills
Pending FDA User-Fee Legislation May Be ‘Big Shot’ For Cosmetics Reg Reform
PCPC Statement On Cosmetics Reform Legislation Hints At Potential Compromises
ICMAD Looks To Sway Legislators To Sessions Cosmetics Bill
FDA Looking At Over $20 Million Annually In Proposed Cosmetics Fees





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts